Navigation Links
Alma Lasers Announces Proposed Initial Public Offering
Date:1/3/2008

BUFFALO GROVE, Ill., Jan. 3 /PRNewswire/ -- Alma Lasers Ltd. ("Alma Lasers") announced today that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to its proposed underwritten initial public offering of its ordinary shares.

The initial public offering is expected to consist of newly issued shares being offered by Alma Lasers and secondary shares offered by certain stockholders. In addition, Alma Lasers expects to grant the underwriters an option to purchase additional ordinary shares to cover over-allotments, if any.

Citigroup Global Markets Inc. and UBS Investment Bank will serve as joint bookrunning managers, William Blair & Company, L.L.C. will serve as lead manager, and Jefferies & Company, Inc. will serve as co-manager for the proposed offering.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement.

Once available, a preliminary prospectus relating to these securities may be obtained by contacting Citigroup Global Markets Inc., Brooklyn Army Terminal, 140 58th Street, Brooklyn, New York 11220, Attn: Prospectus Department or UBS Investment Bank, Prospectus Department, 299 Park Avenue, New York, New York 10171.

About Alma Lasers

Alma Lasers is a global medical technology company that designs, develops, manufactures and markets laser, intense pulsed light and radiofrequency based aesthetic treatment devices that can be used to treat a broad range of skin types and indications. Alma Lasers believes that its products have typically been at the forefront of technological development in the energy-based aesthetic treatment system market. Since commercializing its first aesthetic treatment system in 2002, Alma Lasers has introduced eight systems that work in combination with approximately 19 handpieces. Alma Lasers' mission is to leverage its technical expertise and in-depth understanding of practitioners' needs in order to provide modular, cost-effective and high performance designs that enable medical practitioners to confidently offer safe, effective and profitable aesthetic treatments to their patients.

Alma Lasers. Wellbeing Through Technology.

Contact:

William Bruckner

Vice President, Global Marketing

Tel. 224.377.2010

billb@almalasers.com

Shai Halivni

Vice President, General Counsel

Tel: 224.377.2008

shaih@almalasers.com


'/>"/>
SOURCE Alma Lasers Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Alma Lasers Answers Lumenis Complaint
2. Smart Balance Announces Conversion of Convertible Preferred Stock
3. IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
4. MQ Associates, Inc. Announces Cash Tender Offer for 121/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Related Consent Solicitation
5. Heska Announces Amended Agreement With AgriLabs
6. Versus Technology Announces Fourth Quarter Results
7. FASgen Announces New Research Discoveries in Lung Cancer
8. Boston Scientific Announces CE Mark Approval for Next-Generation Cardiac Resynchronization Therapy Defibrillator
9. KV Pharmaceutical Company Announces NYSE Listing Extension
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
11. Transition Therapeutics Announces Appointment of Vice-President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
Breaking Medicine Technology: